Eli Lilly and Company will establish a new drug delivery and device innovation center in Cambridge, Massachusetts.
The Lilly Cambridge Innovation Center, which will be located in Kendall Square, will allow science experts and organizations to explore how emerging technologies and connectivity can advance drug delivery and device innovation to improve patient health.
"Locating in Cambridge is an important strategic move for achieving this goal, as it provides us access to a concentration of high-caliber academic institutions, cutting-edge life science and technology companies, and some of the world's leading talent," says President and CEO John C. Lechleiter, Ph.D.
Construction will begin immediately with an expected occupancy by the end of 2015.
Over the next couple of years, the company will hire about 30 scientists and engineers.
"We welcome Eli Lilly's expansion here in the Commonwealth, and look forward to their ongoing contributions to our thriving life sciences community," says Governor Charlie Baker.
The company already has existing research facilities in San Diego, New York City and Indianapolis. Eli Lilly and Company has approximately 41,000 employees worldwide.